Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$861.2M
149M shares
52-week range
$2.28 – $7.44
68% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
www.maravai.comNo one on the platform currently holds MRVI.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 4,264,689 | $12.1M |
No one on the platform has traded MRVI yet.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $210M | +13.8% | $-0.11 | $-0.16–$-0.09 | — | 5 |
| 2027 | $226M | +7.3% | $-0.09 | $-0.19–$-0.04 | — | 5 |
| 2028 | $243M | +7.7% | $-0.05 | $-0.05–$-0.05 | — | 1 |
| 2029 | $265M | +8.7% | $-0.14 | $-0.14–$-0.14 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $-0.04 | $-0.02 | +54.1% |
| 2026-05-07 | $-0.05 | $0.01 | +120.0% |
| 2026-02-25 | $-0.07 | $-0.04 | +42.9% |
| 2025-11-06 | $-0.06 | $-0.08 | -33.3% |
| 2025-08-11 | $-0.06 | $-0.08 | -33.3% |
| 2025-05-12 | $-0.07 | $-0.08 | -14.3% |
| 2025-03-18 | $-0.03 | $-0.06 | -100.0% |
| 2024-11-07 | $-0.01 |
| $-0.02 |
| -150.0% |
| +1.51% |
| $896M |
| — |
| LENZLENZ Therapeutics, Inc. | $4.60 | -8.73% | $144M | — |
| PRMEPrime Medicine, Inc. | $3.17 | -0.94% | $573M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$TNYA So I invested in $MRVI at $2 because of Bernd Brust and tripled the money in a year. The market often underestimate the importance of having the right people at the right place. It is a true game changer to have Eric onboard for $TNYA!
View on StockTwits ↗$CABO $MRVI $RMD $TXG $DBX AFTER-HOURS MOVERS: Currently Higher After Earnings: Doximity (DOCS) up 73.8% Atlassian (TEAM) up 32.9% Figs (FIGS) up 23.7% QuinStreet (QNST) up 27.9% Cloudflare (NET) up 16.2% Twilio (TWLO) up 17.0% Natera (NTRA) up 15.4% Akamai (AKAM) up 12.1% Onto Innovation (ONTO) up 13.0% Airbnb (ABNB) up 7.8% Instacart (CART) up 9.9% Currently Also Higher: DoubleVerify (DV) up 13.2% after Nielsen agreed to acquire the company in an all-cash transaction valued at roughly $2.15B Currently Lower After Earnings: Trade Desk (TTD) down 24.3% QuidelOrtho (QDEL) down 23.1% Xponential Fitness (XPOF) down 12.7% Cable One (CABO) down 9.5% Maravai Lifesciences (MRVI) down 7.2% ResMed (RMD) down 5.9% 10x Genomics (TXG) down 3.5%. Dropbox (DBX) down 6.5% Post Holdings (POST) down 2.6%
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-8-6-maravai-lifesciences-holdings-inc-stock/ $MRVI Maravai LifeSciences Earnings Transcri
View on StockTwits ↗$MRVI Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.08 up 70.37% YoY • Reported revenue of $51.44M up 8.53% YoY • Maravai LifeSciences maintains its 2026 revenue guidance range of $205.0 million to $215.0 million and raised its full year 2026 Adjusted EBITDA guidance to $33.0 million to $35.0 million.
View on StockTwits ↗I think grandpa Jensen might have misspoke, you know older age can do that. He meant $MRVI not $MRVL
View on StockTwits ↗Closing out the day pretty nicely. Hopefully tomorrow all of these will expire $IREN $AAOI $MRVI $NBIS $TE The detailed stock list and strategies have been shared with the community; please visit my profile to view them.
View on StockTwits ↗$NVDA ahahaha here is a quick snapshot to all Nvidia longs (aka bag holders). $AMD up 10% and $MRVI up 6% TODAY. One trading at 180 pe the other at 110. Rhis turd at 30 pe is up 0.5%. Who da f is dumb enough to buy this? People are willing to pay 6 times more to buy anything but this. This turd won’t gain what $AMD gained today in 2 years lol
View on StockTwits ↗$MRVI Share Price: $4.99 Contract Selected: Dec 18, 2026 $5 Calls Buy Zone: $0.64 – $0.79 Target Zone: $1.20 – $1.47 Potential Upside: 78% ROI Time to Expiration: 195 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$MRVI Lol. Who's selling at these levels and making money?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.